Is ketamine a safe anesthetic for percutaneous liver biopsy in a liver transplant recipient immunosuppressed with cyclosporine?

Anesthesia and Analgesia

Volumn 100, Issue 1, 2005, Pages 85-86

  Agarwal, Anil ^a   Raza, Mehdi ^a   Dhiraaj, Sanjay ^a   Saxena, Rajan ^a   Singh, Prabhat K ^a   Pandey, Ravindra ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN A; GLYCOPYRRONIUM BROMIDE; KETAMINE; MIDAZOLAM; THIOPENTAL;

AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ARTICLE; CASE REPORT; DRUG SAFETY; ELECTROENCEPHALOGRAM; GENERAL ANESTHESIA; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PORTAL HYPERTENSION; PREOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

ANESTHETICS, DISSOCIATIVE; BIOPSY; CHILD; CYCLOSPORINE; ELECTROENCEPHALOGRAPHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETAMINE; LIVER; LIVER TRANSPLANTATION; MALE; SEIZURES;

EID: 10944241523     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000139373.26517.C4     Document Type: Article

References (14)

1. Modica PA, Tempelhoff R, White PF. Pro and anticonvulsant effects of anesthetics (Part II). Anesth Analg 1990;70:433-44.
2. Taylor C, Stoelting VK. Methohexitone sodium: a new ultra short acting barbiturate. Anesthesiology 1960;21:29-34.
3. Steen PA, Michenfelder J. Neurotoxicity of anesthetics. Anesthesiology 1979;50:437-53.
4. Bennet DR, Amdsen JA, Jordan WS, Wiser WC. Ketamine anesthesia in brain damaged epileptics: electroencephalographic and clinical observations. Neurology 1973;23:449-60.
5. White PF, Schuttler J, Shafer A, et al. Comparative pharmacology of ketamine isomers. Br J Anaesth 1985;57:197-203.
6. Khanna N, Bhalla S. Role of ketamine in convulsions. Indian J Med Sci 1999;53:475-80.
7. Sofia RD, Gordan R, Gels M, Diamantis W. Comparative effect of felbamate and other compounds on N-methyl-D-aspartic acid induced convulsions and lethality in mice. Pharmacol Res 1994;29:139-44.
8. Williams ML, Wainer IW. Role of chiral chromatography in therapeutic drug monitoring and in clinical and forensic toxicology. Ther Drug Monit 2002;24:290-6.
9. MacManus RJ, O'Hair DP, Schwringer J, et al. Cyclosporine associated central neurotoxicity after heart transplantation. Ann Thorac Surg 1992;53:322-7.
10. Shuto H, Kakaoka Y, Fujisaki K, et al. Inhibition of GABA system involved in cyclosporine-induced convulsions. Life Sci 1999;65:879-89.
11. Fujisaki Y, Yamauchi A, Dohgu S, et al. Cyclosporine-A induced nitric oxide production in the rat dorsal hippocampus mediates convulsions. Life Sci 2002;72:549-56.
12. Akhlaghi F, Keogh AM, McLachlan AJ, Kaan A. Pharmacokinetics of Cyclosporine in heart transplant recipients receiving metabolic inhibitors. J Heart Lung Transplant 2001;20:431-8.
13. Yamaguchi S, Hashizume Y, Mishio M, et al. Anesthetic management for urgent endoscopy in a child with heterotopic liver transplant. Masui 1999;48:1235-7.
14. Scott JP, Higenbottam JW. Adverse reactions and interactions of Cyclosporine. Med Toxicol Adverse Drug Exp 1988;13:107-27.